Claims
- 1. Process to separate linear 5-formylvalerate compound from a crude mixture comprising 5-formylvalerate compound and 2-, 3- and/or 4-formylvalerate compound by vacuum distillation, characterized in that the distillation is performed in the presence of a phenolic compound with a boiling point which is at least 10° C. higher than the boiling point of the 5-formylvalerate at 0.1-100 kPa.
- 2. Process according to claim 1 wherein the phenolic compound has a boiling point which is at least 20° C. higher than the boiling point of the 5-formylvalerate at 0.1-100 kPa.
- 3. Process according to claim 1, wherein the phenolic compound is fed to the top of the distillation column.
- 4. Process according to claim 1, wherein the crude mixture of 5-formylvalerate compound and 2-, 3- and/or 4-formylvalerate compound contains 0.01-0.2 wt. % of the phenolic compound.
- 5. Process accordding to claim 4, wherein the crude mixture contains 0.05-0.15 wt. % of the phenolic compound.
- 6. Process for the continuous preparation of ε-caprolactam, which comprises:(a) hydroformylation of a 3-pentenoate compound in the presence of a hydroformylation catalyst to a crude mixture comprising linear and branched formylvalerate compounds and unconverted pentenoate compounds, (b) separation the catalyst from the crude mixture obtained in step (a) and recycling the catalyst to step (a), (c) separation of linear and branched formylvalerate compounds from the unconverted pentenoate compounds, (d) separation of the linear 5-formylvalerate from the crude mixture of linear and branched formylvalerate compounds obtained in step (c) vacuum distilling the crude mixture in the presence of a phenolic compound with a boiling point which is at least 10° C. higher than the boiling point of the 5-formylvalerate at 0.1 to 100 kPa, (e) separation of the phenolic compound from the linear 5-formylvalerate compound obtained in step (a) by vacuum distillation at a temperature of 50-200° C. and a pressure of 0.1-100 kPa resulting in a fraction containing the linear aldehyde and a fraction containing the phenolic compound, (f) reusing the phenolic compound obtained in step (e) in step (d), (g) reductively aminating of the linear 5-formylvalerate compound (or a derivative thereof) obtained in step (e) to a mixture comprising an amino intermediate compound and ε-caprolactam, and (h) cyclising the amino intermediate compound mixture obtained in step (g) (or a derivative thereof) to ε-caprolactam at elevated temperature.
- 7. Process according to claim 6, wherein the separation of linear and branched formylvalerate compounds from pentenoate compounds in step (c) is performed by vacuum distillation in the presence of the phenolic compound.
- 8. Process according to claim 6, wherein the separated phenolic compound obtained in step (e) is reused in separation step (c) or (d).
- 9. Process according to claim 7, wherein the phenolic compound is fed to the top of the distillation column of separation step (c) or (d).
- 10. Process according to claim 6, wherein, after having separated the phenolic compound from the linear 5-FORMYLVALERATE compound in step (e), a part of the fraction containing the phenolic compound is purged and the rest is recycled to step (c) or (d).
- 11. A process according to claim 1, wherein the formylvalerate compound is a C1-C6 alkyl formylvalerate compound.
- 12. A process according to claim 11, wherein the alkyl formylvalerate compound is methyl or ethyl formylvalerate.
- 13. A process to separate linear and branched formylvalerate compounds from pentenoate compound(s) by vacuum distillation in the presence of a phenolic compound with a boiling point which is at least 10° C. higher than the boiling point of the linear formylvalerate compound at 0.1-100 kPa.
- 14. Process according to claim 6, which further comprises isolating the ε-caprolactam from step (h).
Priority Claims (1)
Number |
Date |
Country |
Kind |
99200457 |
Feb 1999 |
EP |
|
Parent Case Info
This Application is a continuation of International Application PCT/NL00/00067, filed Feb. 3, 2000, which designated the U.S. and was published in the English language. The entire contents of this PCT application are hereby incorporated by reference.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4730041 |
Hutmacher et al. |
Mar 1988 |
A |
Foreign Referenced Citations (4)
Number |
Date |
Country |
2225649 |
Feb 1999 |
CA |
295551 |
Dec 1998 |
EP |
56-70097 |
Jun 1981 |
JP |
9706126 |
Feb 1997 |
WO |
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/NL00/00067 |
Feb 2000 |
US |
Child |
09/930502 |
|
US |